Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · IEX Real-Time Price · USD
7.04
+0.45 (6.83%)
At close: Mar 27, 2024, 4:00 PM
6.63
-0.41 (-5.82%)
Pre-market: Mar 28, 2024, 5:47 AM EDT
Monte Rosa Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for GLUE stock have an average target of 11, which predicts an increase of 56.25% from the current stock price of 7.04.
Analyst Consensus: Buy
* Price targets were last updated on Feb 15, 2024.
Analyst Ratings
The average analyst rating for GLUE stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Oct '23 | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wedbush | Wedbush | Buy Initiates $11 | Buy | Initiates | $11 | +56.25% | Feb 15, 2024 |
JP Morgan | JP Morgan | Buy Maintains $31 → $11 | Buy | Maintains | $31 → $11 | +56.25% | Oct 19, 2023 |
Credit Suisse | Credit Suisse | Hold Reiterates $11 | Hold | Reiterates | $11 | +56.25% | Aug 11, 2023 |
Credit Suisse | Credit Suisse | Hold Reiterates $11 | Hold | Reiterates | $11 | +56.25% | May 12, 2023 |
Credit Suisse | Credit Suisse | Hold Maintains $12 → $11 | Hold | Maintains | $12 → $11 | +56.25% | Mar 17, 2023 |
Financial Forecast
Revenue This Year
4.61M
Revenue Next Year
6.05M
from 4.61M
Increased by 31.17%
EPS This Year
-2.74
from -2.63
EPS Next Year
-2.42
from -2.74
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 17.5M | 17.5M | 81.9M | 368.6M | 671.0M |
Avg | 4.6M | 6.1M | 19.9M | 127.0M | 281.9M |
Low | n/a | n/a | n/a | n/a | 39.4M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | 279.3% | 1,253.3% | 1,752.9% | 428.3% |
Avg | - | 31.2% | 228.7% | 538.5% | 122.0% |
Low | - | - | - | - | -69.0% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -2.48 | -1.94 | -1.76 | 1.49 | 4.75 |
Avg | -2.74 | -2.42 | -2.57 | -1.37 | 0.26 |
Low | -3.19 | -2.87 | -3.34 | -2.79 | -2.17 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.